Ignite Creation Date:
2025-12-24 @ 7:36 PM
Ignite Modification Date:
2025-12-29 @ 1:06 PM
Study NCT ID:
NCT00776503
Status:
COMPLETED
Last Update Posted:
2014-03-20
First Post:
2008-10-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Vorinostat and Low Dose Cytarabine for High Risk Myelodysplasia
Sponsor:
Groupe Francophone des Myelodysplasies
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GFM VOR 2007-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |